Interestingly, the treatment of type 2 diabetes with metformin results in a significant fall in urinary MIF and CD74 excretion, suggesting that the anti-inflammation mechanism of metformin reduces podocyte injury and albuminuria by suppressing MIF-CD74-mediated renal inflammation [69]. This evidence concerns the gene MIF and type 2 diabetes mellitus.